More importantly, the overexpression of FLT3 significantly restored the cell expansion in the RBM5 sgRNA-treated leukemia cells, similar to the extent of both RBM5 and HOXA9 overexpression (Fig. 7f, g). This evidence concerns the gene FLT3 and leukemia.